


Ask a doctor about a prescription for FESOTERODINE ALTER 8 mg PROLONGED-RELEASE TABLETS
Patient Information Leaflet
Fesoterodina Alter 4 mg prolonged-release tablets EFG
Fesoterodina Alter 8 mg prolonged-release tablets EFG
Fesoterodina, fumarate
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Leaflet
This medication contains the active ingredient fesoterodina fumarate and is a treatment called antimuscarinics, which reduce the activity of the overactive bladder and is used in adults to treat symptoms.
Fesoterodina treats symptoms of an overactive bladder, such as:
Do not take Fesoterodina Alter
Warnings and precautions
Consult your doctor or pharmacist before starting to take Fesoterodina Alter.
Fesoterodina may not always be suitable for you. Talk to your doctor before taking fesoterodina in any of the following cases:
Cardiac problems: Inform your doctor if you have any of the following conditions:
Children and adolescents
Do not give this medication to children and adolescents under 18 years of age, as it has not been established whether it is effective and safe for them.
Other medications and Fesoterodina Alter
Tell your doctor or pharmacist if you are taking or have recently taken or may need to take any other medication. Your doctor will tell you if you can use fesoterodina with other medications.
Please inform your doctor if you are taking medications from the list below. Taking these medications at the same time as fesoterodina may cause side effects such as dry mouth, constipation, difficulty emptying the bladder, or more severe or frequent drowsiness.
Please indicate to your doctor if you are taking any of the following medications:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
You should not take fesoterodina if you are pregnant, as the effects of fesoterodina on pregnancy and the newborn are unknown.
It is unknown whether fesoterodina is excreted in breast milk; therefore, do not breastfeed during treatment with this medication.
Driving and using machines
Fesoterodina may cause blurred vision, dizziness, and drowsiness. If you experience any of these effects, do not drive or operate tools or machines.
Fesoterodina Alter contains fructose and lactose
If your doctor has told you that you (or your child) have an intolerance to certain sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medication.
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult your doctor before taking this medication.
Follow the administration instructions for this medication exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
The recommended initial dose is one 4 mg fesoterodina tablet per day. Depending on your response to the medication, your doctor may prescribe a higher dose; one 8 mg fesoterodina tablet per day.
Swallow the tablet whole with a glass of water. Do not chew the tablet. This medication can be taken with or without food.
To help you remember to take your medication, it may be easier to take it at the same time every day.
If you take more Fesoterodina Alter than you should
If you have taken more tablets than you should or if someone else has taken your tablets by accident, contact your doctor or hospital immediately. Show them the package of tablets.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Fesoterodina Alter
If you have forgotten to take a tablet, take it as soon as you remember, but do not take more than one tablet in a day. Do not take a double dose to make up for forgotten doses.
If you stop taking Fesoterodina Alter
Do not stop taking fesoterodina without talking to your doctor first, as the symptoms of an overactive bladder may return or worsen when you stop taking this medication.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Some side effects can be serious
Other side effects
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the package and blister, after "EXP". The expiration date is the last day of the month indicated.
Do not store above 25°C.
Keep in the original packaging to protect from moisture.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and unused medications in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and unused medications. This will help protect the environment.
Composition of Fesoterodina Alter
Fesoterodina Alter 4 mg: Each prolonged-release tablet contains 4 mg of fesoterodina fumarate, equivalent to 3.1 mg of fesoterodina.
Fesoterodina Alter 8 mg: Each prolonged-release tablet contains 8 mg of fesoterodina fumarate, equivalent to 6.2 mg of fesoterodina.
Tablet core: fructose, lactose monohydrate-microcrystalline cellulose spheres, hypromellose, dibehenate, talc.
Tablet coating: poly(vinyl alcohol), titanium dioxide (E171), macrogol, talc, and carmine indigo (E132).
Appearance of the product and package contents
Fesoterodina Alter 4 mg: film-coated tablets, 13.1 x 6.0 mm, blue, elliptical, biconvex, with the engraving "F4" on one side.
Fesoterodina Alter 8 mg: film-coated tablets, 13.1 x 6.0 mm, dark blue, elliptical, biconvex, with the engraving "F8" on one side.
Fesoterodina Alter is available in aluminum-aluminum blisters, in packages containing 28 tablets.
Marketing authorization holder
Laboratorios Alter, S.A.
C/ Mateo Inurria 30
28036 Madrid
Spain
Manufacturer
Laboratorios Normon, S.A.
Ronda de Valdecarrizo 6
28760 Tres Cantos, Madrid
Spain
Or
Laboratorios Liconsa, S.A.
Avda. Miralcampo 7
Polígono Industrial Miralcampo
19200 Azuqueca de Henares, Guadalajara
Spain
Date of the last revision of this leaflet:
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.
The average price of FESOTERODINE ALTER 8 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 35.75 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for FESOTERODINE ALTER 8 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.